Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

The nitazene epidemic in Estonia: a first report

Title: The nitazene epidemic in Estonia: a first report
Authors: Abel-Ollo, Katri; Tõnisson, Mailis; Rausberg, Peep; Riikoja, Aime; Barndõk, Tarmo; Oja, Mikk; Denissov, Gleb; Des Jarlais, Don; Uusküla, Anneli
Contributors: NIHD; EUDA; Estonian Research Council
Source: European Journal of Public Health ; volume 35, issue 6, page 1233-1240 ; ISSN 1101-1262 1464-360X
Publisher Information: Oxford University Press (OUP)
Publication Year: 2025
Description: Since 2022, Estonia, a north-east European nation of 1.3 million people, has faced challenges with nitazenes, a class of novel synthetic opioids, which present a new threat to public health. The purpose of this article is to provide the timeline of the nitazene epidemic in Estonia, examining the prevalence and health consequences of nitazene use in the country. This case study uses a multifaceted approach. Data sources include administrative statistics, surveillance and research data, national service provision information, and government documentation from 2015 to 2024, with a focus on health consequences from 2019 to 2024. Quantitative data is complemented by qualitative interviews with nitazene users. The number of drug-related deaths in Estonia has more than doubled since 2022 (39 vs. 80 cases), exceeding over 100 cases in 2023. The increasing prevalence of nitazenes from 2022 is confirmed by syringe residue studies and seizure data. Nitazenes are often sold on the drug market, usually with no or limited information to the user about the substance being sold. Users frequently describe the effect of nitazenes as stronger, faster, sharper and more short-lived compared to fentanyl. Harm reduction services have seen increased utilization since 2022, with first responders facing growing challenges linked to the emergence of the nitazene phenomenon. This study provides the first comprehensive description of the nitazene epidemic. Results indicate a need for more evidence-based information on the use of nitazenes and their consequences to effectively address emerging challenges.
Document Type: article in journal/newspaper
Language: English
DOI: 10.1093/eurpub/ckaf160
Availability: https://doi.org/10.1093/eurpub/ckaf160; https://academic.oup.com/eurpub/article-pdf/35/6/1233/64357656/ckaf160.pdf
Rights: https://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.774AFBC2
Database: BASE